Skip to main content

Adressing health disparities in HIV therapeutics: the experience of NIH and the Medicines Patent Pool

Friday, November 08, 2013 — Poster Session IV

2:00 p.m. – 4:00 p.m.

FAES Academic Center (Upper-Level Terrace)




  • M.A. Rohrbaugh
  • S.M. Ferguson


The UN has set a target of treating 15 million people infected by HIV in the developing world by 2015. Reaching this goal is possible, but only if appropriate, affordable treatments can be made widely accessible to the people who need them. The Medicines Patent Pool, established by UNITAID in July 2010, is working to bring down the prices of HIV drugs in the developing world and to encourage the development of new formulations, such as medicines for children, through voluntary licensing of critical intellectual property. Although patent pools have proven useful in many areas, such as agriculture and information technology, the Medicines Patent Pool is the first for HIV medicines. This poster will focus on the NIH contribution to the Medicines Patent Pool of certain patents related to the protease inhibitor class of HIV medicines, which is primarily used to treat drug-resistant HIV infection as best exemplified to date by the drug darunavir.

back to top